Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disparity in initiation of checkpoint inhibitors among commercially insured and Medicare Advantage patients with metastatic melanoma

Published:2023-11 Issue:11 Volume:29 Page:1232-1241
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Li Meng¹,Liao Kaiping¹,Nowakowska Malgorzata²,Wehner Mackenzie¹³,shih Ya-Chen Tina⁴⁵

Affiliation:

1. University of Texas MD Anderson Cancer Center, Department of Health Services Research, Houston.

2. University of Texas Southwestern Medical Center, Department of Dermatology, Dallas.

3. University of Texas MD Anderson Cancer Center, Department of Dermatology, Houston.

4. University of California Los Angeles Jonsson Comprehensive Cancer Center.

5. University of California Los Angeles, David Geffen School of Medicine, Department of Radiation Oncology.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference54 articles.

1. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity–United States, 2000 to 2006

3. Cancer Statistics, 2021

4. American Cancer Society. Cancer facts and figures 2022. Accessed September 2, 2022. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2022/2022-cancer-facts-and-figures.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP